Depression drug trial halted early
NCT ID NCT06618118
Summary
This early-stage study tested a new oral medication called fosigotifator for treating major depressive disorder (MDD). It aimed to see if the drug was safe and effective for adults with depression. The study was terminated early and only involved a small group of participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel CNR /ID# 265866
Sherman Oaks, California, 91403, United States
-
CenExel iResearch, LLC /ID# 265886
Decatur, Georgia, 30030-3440, United States
-
Clinical Neuroscience Solutions - Orlando - East South Street /ID# 265060
Orlando, Florida, 32801, United States
-
Northwest Clinical Research Center /ID# 265057
Bellevue, Washington, 98007, United States
Conditions
Explore the condition pages connected to this study.